Patents by Inventor Celia Hart

Celia Hart has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Specific Binding Members For Ngf
    Publication number: 20080107658
    Abstract: Specific binding members for Nerve Growth Factor (NGF), in particular anti-NGF antibody molecules, especially human antibody molecules, and especially those that neutralise NGF activity. Methods for using anti-NGF antibody molecules in diagnosis or treatment of NGF related disorders, including pain, asthma, chronic obstructive pulmonary disease, pulmonary fibrosis, other diseases of airway inflammation, diabetic neuropathy, cardiac arrhythmias, HIV, arthritis, psoriasis and cancer.
    Type: Application
    Filed: January 24, 2006
    Publication date: May 8, 2008
    Inventors: Ruth Franks, Andrew Buchanan, Albert Thom, Fraser Welsh, Philip Bland-Ward, Matthew Sleeman, Carl Matthews, Celia Hart, Jon Hawkinson
  • Antibodies to TGF-beta
    Publication number: 20070264255
    Abstract: The present invention relates to antibody molecules, in particular antibody molecules that bind Transforming Growth Factor beta (TGF?), and uses thereof. More particularly, the invention relates to antibody molecules that bind and preferably neutralise TGF?1, TGF?2 and TGF?3, so-called “pan-specific” antibody molecules, and uses of such antibody molecules. Preferred embodiments within the present invention are antibody molecules, whether whole antibody (e.g. IgG, such as IgG1 or IgG4) or antibody fragments (e.g. scFv, Fab, dAb).
    Type: Application
    Filed: January 30, 2007
    Publication date: November 15, 2007
    Inventors: Steven Ledbetter, Celia Hart, Robert Holgate, Lutz Jermutus, Catriona Buchanan, Alexander Duncan, Donna Finch
  • Antibodies to TGF-BETA
    Publication number: 20070134246
    Abstract: The present invention relates to antibody molecules, in particular antibody molecules that bind Transforming Growth Factor beta (TGF?), and uses thereof. More particularly, the invention relates to antibody molecules that bind and preferably neutralise TGF?1, TGF?2 and TGF?3, so-called “pan-specific” antibody molecules, and uses of such antibody molecules. Preferred embodiments within the present invention are antibody molecules, whether whole antibody (e.g. IgG, such as IgG1 or IgG4) or antibody fragments (e.g. scFv, Fab, dAb).
    Type: Application
    Filed: January 30, 2007
    Publication date: June 14, 2007
    Inventors: Steven Ledbetter, Celia Hart, Robert Holgate, Lutz Jermutus, Catriona Buchanan, Alexander Duncan, Donna Finch
  • Antibodies to TGF-beta
    Publication number: 20060251658
    Abstract: The present invention relates to antibody molecules, in particular antibody molecules that bind Transforming Growth Factor beta (TGF?), and uses thereof. More particularly, the invention relates to antibody molecules that bind and preferably neutralise TGF?1, TGF?2 and TGF?3, so-called “pan-specific” antibody molecules, and uses of such antibody molecules. Preferred embodiments within the present invention are antibody molecules, whether whole antibody (e.g. IgG, such as IgG1 or IgG4) or antibody fragments (e.g. scFv, Fab, dAb).
    Type: Application
    Filed: February 8, 2006
    Publication date: November 9, 2006
    Inventors: Steven Ledbetter, Celia Hart, Robert Holgate, Lutz Jermutus, Catriona Buchanan, Alexander Duncan, Donna Finch